Tarah Jean Ballinger

16PUBLICATIONS
110CO-AUTHORS
Epidemiological modellingMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 30, 2026
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

|Apr 14, 2026
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.

Kathy D Miller, Alexandra Thomas, Sandra Althouse

|Jan 23, 2025
Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence.

Jennifer W Bea, Heather M Ochs-Balcom, Celina I Valencia

|Oct 25, 2024
Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer.

Catherine E Mosher, Shieun Lee, Elizabeth L Addington

|Oct 08, 2024
Discerning the impact of ctDNA detection on patient decision-making in early-stage breast cancer.

Tarah J Ballinger, Mary Lou Smith, Elda Railey

|Jul 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).

Adrienne G Waks, Emily L Chen, Noah Graham

Pageof 3

Frequent Collaborators

5 joint publications

Bryan P Schneider

5 joint publications

Kathy D Miller

3 joint publications

Fei Shen

3 joint publications

Anna Maria V Storniolo